FADCX
Price
$25.14
Change
+$0.36 (+1.45%)
Updated
Apr 24 closing price
Net Assets
1.39B
RERBX
Price
$52.58
Change
+$0.62 (+1.19%)
Updated
Apr 24 closing price
Net Assets
123.11B
Ad is loading...

FADCX vs RERBX

Header iconFADCX vs RERBX Comparison
Open Charts FADCX vs RERBXBanner chart's image
Fidelity Advisor Diversified Intl C
Price$25.14
Change+$0.36 (+1.45%)
VolumeN/A
Net Assets1.39B
American Funds Europacific Growth R2
Price$52.58
Change+$0.62 (+1.19%)
VolumeN/A
Net Assets123.11B
FADCX vs RERBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FADCX vs. RERBX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FADCX is a Buy and RERBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RERBX has more cash in the bank: 123B vs. FADCX (1.39B). FADCX pays higher dividends than RERBX: FADCX (0.77) vs RERBX (0.48). FADCX was incepted earlier than RERBX: FADCX (26 years) vs RERBX (23 years). FADCX (1.87) is less costly to investors than RERBX (1.56). FADCX is a more actively managed with annual turnover of: 33.00 vs. RERBX (30.00). FADCX has a lower initial minimum investment than RERBX: FADCX (0) vs RERBX (250). FADCX annual gain was more profitable for investors over the last year : 2.30 vs. RERBX (-2.89). FADCX return over 5 years is better than : 25.74 vs. RERBX (22.64).
FADCXRERBXFADCX / RERBX
Total Expense Ratio1.871.56120%
Annual Report Gross Expense Ratio1.871.56120%
Fund Existence26 years23 years-
Gain YTD6.2613.402184%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.39B123B1%
Annual Yield % from dividends0.770.48158%
Returns for 1 year2.30-2.89-80%
Returns for 3 years8.445.24161%
Returns for 5 years25.7422.64114%
Returns for 10 years22.786.44354%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIR6.290.32
+5.36%
Vir Biotechnology
PRTG9.270.29
+3.23%
Portage Biotech Inc
KOF98.410.74
+0.76%
Coca-Cola FEMSA SAB DE CV
AMTD1.02N/A
N/A
AMTD IDEA Group
ELDN3.36N/A
N/A
Eledon Pharmaceuticals